The Ikaros transcription factor regulates responsiveness to IL-12 and expression of IL-2 receptor alpha in mature, activated CD8 T cells.
about
Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production.Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients
P2860
The Ikaros transcription factor regulates responsiveness to IL-12 and expression of IL-2 receptor alpha in mature, activated CD8 T cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The Ikaros transcription facto ...... mature, activated CD8 T cells.
@ast
The Ikaros transcription facto ...... mature, activated CD8 T cells.
@en
The Ikaros transcription facto ...... mature, activated CD8 T cells.
@nl
type
label
The Ikaros transcription facto ...... mature, activated CD8 T cells.
@ast
The Ikaros transcription facto ...... mature, activated CD8 T cells.
@en
The Ikaros transcription facto ...... mature, activated CD8 T cells.
@nl
prefLabel
The Ikaros transcription facto ...... mature, activated CD8 T cells.
@ast
The Ikaros transcription facto ...... mature, activated CD8 T cells.
@en
The Ikaros transcription facto ...... mature, activated CD8 T cells.
@nl
P2093
P2860
P1433
P1476
The Ikaros transcription facto ...... mature, activated CD8 T cells.
@en
P2093
Alexandria David
Bernard Collins
Eric T Clambey
Jens Eberlein
Mary H Young
P2860
P304
P356
10.1371/JOURNAL.PONE.0057435
P407
P577
2013-02-26T00:00:00Z